Financial Daily from THE HINDU group of publications
Saturday, Mar 25, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals
Agri-Biz & Commodities - Poultry


WHO calls meet with Asian drug firms on bird flu

P.T. Jyothi Datta

To discuss the companies' preparedness in the event of a pandemic


Being prepared
Health Ministry officials from India and representatives from other countries would present their plans to tackle the avian-flu.
Drug companies will then be able to understand the requirement of the different countries and vice-versa.
WHO will only facilitate the interface between the buyer and seller.


CHICKENS IN a poultry farm.

Mumbai , March 24

As South-East Asian countries report cases of bird-flu jumping species and infecting humans, the World Health Organisation (WHO) has called for a meeting on the "pandemic preparedness" in this region.

The meeting scheduled to be held in Delhi later this month will bring together health representatives from India, Indonesia, Thailand and Bangladesh, along with drug companies from these countries to discuss their preparedness in the event of a pandemic, a WHO official told Business Line.

Stock piling Oseltamivir, the drug recommended for the treatment of bird-flu, is just one component of the preparedness plan.

As part of the over-all state of preparedness, the regional production capacity of Oseltamivir is on the agenda for discussion, the official confirmed. However, it is unclear whether Roche, the Swiss-company that markets Oseltamivir globally under the brand name Tamiflu, will be at this meeting.

But Indian drug majors such as Cipla, Ranbaxy and Natco, Bangladesh's Beximco and other drug companies from Indonesia and Thailand are expected to participate. Hetero, the only Indian company to have a sub-licence from Roche to make and market Oseltamivir, has also been invited, the official said.

The Roche Managing Director in India, Dr G.L. Telang, confirmed that they have been invited to the meeting. But he was unwilling to divulge whether they would participate in the meeting. A WHO official familiar with the meeting, however, indicated that Roche was unlikely to participate.

At the meeting, Health Ministry officials from India and representatives from other countries would present their plans to tackle the avian-flu.

Drug companies will then be able to understand the requirement of the different countries and vice-versa, the official said.

Currently, drug companies in India, for instance, are executing export orders from neighbouring countries in their individual capacities.

WHO will not get involved with the procurement and will only facilitate the interface between the buyer and seller, the official clarified.

According to WHO, among the human cases that have been reported, most of them are in Asia.

In the South-East Asian region alone, Indonesia has reported 27 confirmed human cases of avian influenza, with 20 deaths and Thailand has had 22 confirmed human cases of avian influenza since December 2003, according to WHO.

India has not reported any human case of the disease till date.

Related Stories:
Hetero to sell bird-flu drug to Indonesia, Bangladesh
Patient vs Patent debate: Move on Tamiflu to set the trend
Ranbaxy exporting Tamiflu

More Stories on : Pharmaceuticals | Poultry | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
States approach Centre with development plans for cities


Urban projects to get Rs 1,100 cr
Manpower recruitment in B-schools
Bay clouds promise breezy wet session
Jain Irrigation's $60-m FCCB issue
4 in race for coal PF assets management
Content vs process
BOC opens merchant plant in South
Panel clears Rs 27,000-cr plans in Karnataka
Indo-UK business awards instituted
CII MoUs with Ballarat, Melbourne
GlaxoSmithKline gets nod to import bird flu drug
Mass death of chickens triggers panic in Coimbatore
M&M to develop Rs 2,000-cr SEZ in Pune
KMML awards Rs 160-cr deal to Finnish company
STC aiming at Rs 10,000-cr turnover next year
ONGC to realise higher price for PMT gas
GAIL gets bids from 8 cos
`Bangladesh nod awaited on Myanmar pipeline'
RPL to set up two SBMs at Jamnagar
`Refining capacity to touch 210 mt by 2012'
Jindal Drilling signs deal with Keppels Felles for second rig
Petronet LNG to source gas from Australia
HPCL to go ahead with Bhatinda project alone
IOC includes E&P bids as part of MoU with Govt
WHO calls meet with Asian drug firms on bird flu
No guarantees for ultra mega power projects
Shankaralingam is new NTPC chief
Domestic power tariff to stay in AP
Karnataka's tax coverage close to 12% of GSDP
Visvesvaraya Award
Ministry to seek Cabinet nod for CIL venture
Mobile TV set to power ahead
`Restructuring part of larger expansion plans'
Tech fest at IIT-M
Visvesvaraya varsity completes 1,000th class
DSK Developers eyeing Hyderabad
New Chairman of CII (Andhra)
`CPTs would boost audiovisual sector'
Rubber dealers oppose FDI in processing
Nabard sanctions Rs 19.69 cr for Kerala
London woos investors
2-day meet on `intellectual capital'
Rajshree Pathy awarded `Woman of the Year'
Target Plus scheme may be buried after March 31
ECGC unveils scheme to provide credit risk cover
DEPB scheme extended by a year
Zenith Computers sees Rs 100-cr export sales
CII meet calls to boost medical tourism in Kerala
Holidays in Australia just clicks away



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line